Dacemazine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H16N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88D34UY0QI, chemically known as 10-n,n-dimethylglycylphenothiazine but generally known as dacemazine, which bears US NIH Compound Identifier 68846. European Medicines Agency schedules Dacemazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06883MIG. The term DACEMAZINE is an International Non-Proprietary Name. DACEMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dacemazine under HS 29343090 and SITC 51578. As of Q4 2014, DACEMAZINE remains the US FDA Preferred Term for this commodity. Dacemazine bears US NLM identifiers UMLS ID C2348067 and NCI Concept Code C73047. SMILES: S1C2C(N(C3C1CCCC3)C(=O)CN(C)C)CCCC2.